130 related articles for article (PubMed ID: 11435884)
1. Excretion of bikunin and its fragments in the urine of patients with renal stones.
Suzuki M; Kobayashi H; Kageyama S; Shibata K; Fujie M; Terao T
J Urol; 2001 Jul; 166(1):268-74. PubMed ID: 11435884
[TBL] [Abstract][Full Text] [Related]
2. Differential expression of urinary inter-alpha-trypsin inhibitor trimers and dimers in normal compared to active calcium oxalate stone forming men.
Marengo SR; Resnick MI; Yang L; Chung JY
J Urol; 1998 May; 159(5):1444-50. PubMed ID: 9554330
[TBL] [Abstract][Full Text] [Related]
3. Role of urinary bikunin in the inhibition of calcium oxalate crystallization.
Atmani F; Khan SR
J Am Soc Nephrol; 1999 Nov; 10 Suppl 14():S385-8. PubMed ID: 10541269
[TBL] [Abstract][Full Text] [Related]
4. A simple procedure for isolating microgram quantities of biologically active bikunin from human urine.
Yang L; Resnick MI; Marengo SR
BJU Int; 2005 Sep; 96(4):647-53. PubMed ID: 16104926
[TBL] [Abstract][Full Text] [Related]
5. Inter-alpha-inhibitor: a protein family involved in the inhibition of calcium oxalate crystallization.
Atmani F; Mizon J; Khan SR
Scanning Microsc; 1996; 10(2):425-33; discussion 433-4. PubMed ID: 9813621
[TBL] [Abstract][Full Text] [Related]
6. [The effects of the active constituents of Alisma orientalis on renal stone formation and bikunin expression in rat urolithiasis model].
Cao ZG; Liu JH; Zhou SW; Wu W; Yin CP; Wu JZ
Zhonghua Yi Xue Za Zhi; 2004 Aug; 84(15):1276-9. PubMed ID: 15387965
[TBL] [Abstract][Full Text] [Related]
7. Bikunin prevents adhesion of calcium oxalate crystal to renal tubular cells in human urine.
Ebisuno S; Nishihata M; Inagaki T; Umehara M; Kohjimoto Y
J Am Soc Nephrol; 1999 Nov; 10 Suppl 14():S436-40. PubMed ID: 10541279
[TBL] [Abstract][Full Text] [Related]
8. Whole urinary proteins coat calcium oxalate monohydrate crystals to greatly decrease their adhesion to renal cells.
Kumar V; Farell G; Lieske JC
J Urol; 2003 Jul; 170(1):221-5. PubMed ID: 12796693
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory effect of bikunin on calcium oxalate crystallization in vitro and urinary bikunin decrease in renal stone formers.
Médétognon-Benissan J; Tardivel S; Hennequin C; Daudon M; Drüeke T; Lacour B
Urol Res; 1999; 27(1):69-75. PubMed ID: 10092156
[TBL] [Abstract][Full Text] [Related]
10. Inter-alpha-inhibitor in calcium stones.
Dawson CJ; Grover PK; Kanellos J; Pham H; Kupczyk G; Oates A; Ryall RL
Clin Sci (Lond); 1998 Aug; 95(2):187-93. PubMed ID: 9680501
[TBL] [Abstract][Full Text] [Related]
11. The urinary response to an oral oxalate load in recurrent calcium stone formers.
Krishnamurthy MS; Hruska KA; Chandhoke PS
J Urol; 2003 Jun; 169(6):2030-3. PubMed ID: 12771711
[TBL] [Abstract][Full Text] [Related]
12. Expression of bikunin mRNA in renal epithelial cells after oxalate exposure.
Iida S; Peck AB; Byer KJ; Khan SR
J Urol; 1999 Oct; 162(4):1480-6. PubMed ID: 10492241
[TBL] [Abstract][Full Text] [Related]
13. Changes in urinary stone risk factors in hypocitraturic calcium oxalate stone formers treated with dietary sodium supplementation.
Stoller ML; Chi T; Eisner BH; Shami G; Gentle DL
J Urol; 2009 Mar; 181(3):1140-4. PubMed ID: 19152919
[TBL] [Abstract][Full Text] [Related]
14. Acute caffeine effects on urine composition and calcium kidney stone risk in calcium stone formers.
Massey LK; Sutton RA
J Urol; 2004 Aug; 172(2):555-8. PubMed ID: 15247728
[TBL] [Abstract][Full Text] [Related]
15. Plasma bikunin as a favorable prognostic factor in ovarian cancer.
Matsuzaki H; Kobayashi H; Yagyu T; Wakahara K; Kondo T; Kurita N; Sekino H; Inagaki K; Suzuki M; Kanayama N; Terao T
J Clin Oncol; 2005 Mar; 23(7):1463-72. PubMed ID: 15735122
[TBL] [Abstract][Full Text] [Related]
16. Expression of inter-alpha inhibitor related proteins in kidneys and urine of hyperoxaluric rats.
Moriyama MT; Glenton PA; Khan SR
J Urol; 2001 May; 165(5):1687-92. PubMed ID: 11342956
[TBL] [Abstract][Full Text] [Related]
17. Local factors compared with systemic factors in the formation of bladder uric acid stones.
Li WM; Chou YH; Li CC; Liu CC; Huang SP; Wu WJ; Huang CH
Urol Int; 2009; 82(1):48-52. PubMed ID: 19172097
[TBL] [Abstract][Full Text] [Related]
18. Concentration of a potent calcium oxalate monohydrate crystal growth inhibitor in the urine of normal persons and kidney stone patients by ELISA-based assay system employing monoclonal antibodies.
Moghadam MF; Tandon C; Aggarwal S; Singla SK; Singh SK; Sharma SK; Varshney GC; Jethi RK
J Cell Biochem; 2003 Dec; 90(6):1261-75. PubMed ID: 14635198
[TBL] [Abstract][Full Text] [Related]
19. Effect of acute acid loading on acid-base and calcium metabolism.
Osther PJ
Scand J Urol Nephrol; 2006; 40(1):35-44. PubMed ID: 16452054
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic efficacy of once-daily oral administration of a Kunitz-type protease inhibitor, bikunin, in a mouse model and in human cancer.
Kobayashi H; Yagyu T; Inagaki K; Kondo T; Suzuki M; Kanayama N; Terao T
Cancer; 2004 Feb; 100(4):869-77. PubMed ID: 14770446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]